DHMYX
Price
$26.70
Change
-$0.29 (-1.07%)
Updated
Dec 17 closing price
VSIAX
Price
$88.58
Change
-$1.09 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

DHMYX vs VSIAX

Header iconDHMYX vs VSIAX Comparison
Open Charts DHMYX vs VSIAXBanner chart's image
Diamond Hill Small-Mid Cap Y
Price$26.70
Change-$0.29 (-1.07%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$88.58
Change-$1.09 (-1.22%)
VolumeN/A
CapitalizationN/A
DHMYX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHMYX vs. VSIAX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHMYX is a Sell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. DHMYX (1.23B). VSIAX pays higher dividends than DHMYX: VSIAX (2.01) vs DHMYX (1.27). DHMYX was incepted earlier than VSIAX: DHMYX (13 years) vs VSIAX (13 years). DHMYX (16.00) and VSIAX (16.00) have comparable annual turnover. VSIAX has a lower initial minimum investment than DHMYX: VSIAX (3000) vs DHMYX (500000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. DHMYX (5.97). VSIAX return over 5 years is better than : 52.83 vs. DHMYX (21.73).
DHMYXVSIAXDHMYX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD4.50115.03130%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B63B2%
Annual Yield % from dividends1.272.0163%
Returns for 1 year5.9716.2337%
Returns for 3 years0.0820.670%
Returns for 5 years21.7352.8341%
Returns for 10 years55.09105.6552%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics